hotspot -WSS

hotspot

author：comprehensive 2025-09-05 13:41:59 - browse：821

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Biden's order seeks to regulate AI risk without stifling innovation

hotspot

knowledge

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Chimpanzees, like humans and whales, get menopause: Study

Medtronic CEO on promising devices for diabetes, hypertension

ASCO eve: Let’s set the table for this year's meeting

Fentanyl is making it harder to start addiction treatment

Biogen joins immunology wave with $1.15 billion acquisition of HI

entertainment

hotspot

explore

In Memoriam: Notable people who died in 2023

As a primary care physician, here's how I hope to partner with AI

At least 13 dead in Texas as scorching temps continue

Medtronic CEO on promising devices for diabetes, hypertension

Apple is now the first public company to be valued at $3 trillion

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Hollywood unions extend contract negotiations for actors

Telehealth options flood the market as retailers push virtual care

Supreme Court strikes down use of affirmative action

Physician subsidies by hospitals soar in wake of No Surprises Act

Wikipedia

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Making the case for fair compensation in clinical trials

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

WHO may add ‘noma' to its list of neglected tropical diseases

For longer

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

hotspot

knowledge

leisure time

Wikipedia